GlassScriptPhysician profile
Frank J Ponce
NPI 1497956734
$7,468.23
in general payments reported to CMS, 2019-2025
37 companies · $838 in 2025
The $838 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $842 · 2020: $1,248 · 2021: $1,336 · 2022: $1,192 · 2023: $1,117 · 2024: $895 · 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,850.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,860.60 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $819.33 | 2019-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $770.59 | 2021-2025 | |
| Lilly USA, LLC | $743.93 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $554.29 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $333.85 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $305.30 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $252.86 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $245.76 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $220.89 | 2019-2022 | |
| Amgen INC. | $169.35 | 2020-2025 | Repatha, Repatha, Otezla |
| Abbott Laboratories | $128.85 | 2022-2024 | Proclaim, Freestyle Libre 3, Eterna |
| Pfizer INC. | $122.06 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $109.26 | 2020-2021 | |
| Harmony Biosciences LLC | $80.62 | 2024-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $76.92 | 2022-2025 | Quviviq, Quviviq |
| Avvisto Therapeutics, LLC | $71.38 | 2025 | Cycloset |
| Inspire Medical Systems, INC. | $67.62 | 2024-2025 | Inspire |
| Boston Scientific Corporation | $61.48 | 2022-2023 | |
| Gilead Sciences, INC. | $47.01 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $46.43 | 2022-2023 | Rexulti |
| Corcept Therapeutics | $42.61 | 2025 | Korlym |
| Supernus Pharmaceuticals, INC. | $36.90 | 2023 | |
| Eisai INC. | $33.07 | 2021 | |
| Neos Therapeutics, LP | $30.78 | 2023 | Adzenys Xr-Odt |
| Corium, LLC | $27.14 | 2023 | Azstarys |
| Antares Pharma, INC. | $26.56 | 2020-2023 | Xyosted, Tlando, Nocdurna |
| Tris Pharma INC | $22.25 | 2025 | Dyanavel Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.77 | 2023 | |
| Inari Medical, INC. | $21.34 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Renalytix Ai, INC. | $18.97 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Biohaven Pharmaceuticals, INC. | $18.96 | 2021 | |
| Exact Sciences Corporation | $18.69 | 2023 | Cologuard Collection Kit |
| Dermira, INC. | $18.29 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.61 | 2022 | |
| Horizon Therapeutics Plc | $14.28 | 2020 | |
| Almatica Pharma LLC | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Ponce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.